Ira S. Strassberg - 15 Mar 2022 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Financial Officer
Signature
/s/ Ira S. Strassberg
Issuer symbol
NRXP
Transactions as of
15 Mar 2022
Net transactions value
$0
Form type
3
Filing time
24 Mar 2022, 18:25:58 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NRXP Employee Stock Option Plan (Right to Buy) 15 Mar 2022 Common Stock, par value $0.001 212,500 $3.10 Direct
holding NRXP Employee Stock Option Plan (Right to Buy) 15 Mar 2022 Common Stock, par value, $001 212,500 $3.10 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.